CCTA Enhances Assessment of LV Diastolic Dysfunction in CAD Patients with Normal EF: Study Finds
India: A recent study highlights the growing role of Cardiac CT Angiography (CCTA) in assessing left ventricular (LV) diastolic dysfunction (DD) in patients with suspected coronary artery disease (CAD) and normal ejection fraction. The research compares the efficacy of CCTA with the traditional method of transthoracic echocardiography (TTE) in evaluating LV diastolic function, revealing promising results for CCTA as a valuable diagnostic tool in this population.
The study, published in the Echocardiography Journal, demonstrates that CCTA-derived diastolic expansion index (DEI), a metric obtained from CCTA scans, is a reliable and reproducible measure for evaluating LV diastolic dysfunction in CAD patients with normal ejection fraction.
The research found that DEI derived from CCTA correlated well with the severity of LV diastolic dysfunction, indicating its potential as a reliable alternative to TTE. The study also highlighted that obstructive coronary artery disease and an increased coronary artery calcium score were significantly associated with worsening degrees of diastolic dysfunction.
Diastolic dysfunction refers to impaired left ventricular relaxation, often resulting from structural or functional heart conditions. Sanjeev Kumar from All India Institute of Medical Sciences in New Delhi, India, and colleagues aimed to evaluate the role of cardiac CT angiography in assessing LV DD in patients with normal ejection fraction (EF) using the diastolic expansion index. They also compared its effectiveness with transthoracic echocardiography, the established gold standard.
The study revealed the following findings:
- The study included 141 patients (60 male), with a mean age of 50.82 ± 10.20 years and a mean heart rate of 84.90 ± 16.15 beats per minute.
- CCTA-derived mean indexed LA volumes were larger than the TTE measurements, with a correlation of r = 0.53.
- A progressive increase in the LA volume index was observed with worsening diastolic dysfunction (DD) grades.
- Excellent inter-observer correlation was found for LA volume index (intra-class correlation coefficient: 0.999) and DEI (0.996).
- Normal LV diastolic function was predicted by a DEI > 1.57, with a sensitivity of 81.6%, specificity of 88.3%, and an area under the curve (AUC) of 0.87.
- Abnormal LV diastolic function was predicted by DEI < 1.46, with sensitivity of 62.5%, specificity of 84.8%, and AUC of 0.848.
- A significant correlation was found between the presence of obstructive CAD and increased calcium score with worsening DD grade.
"The study showed that CCTA-derived DEI is an effective tool for evaluating LV diastolic dysfunction in patients with suspected CAD and normal ejection fraction. Additionally, the presence of obstructive CAD and higher calcium scores were linked to more severe diastolic dysfunction," the researchers wrote.
"These findings suggest that CCTA not only offers a comprehensive view of coronary artery status but also provides valuable insights into the functional impairment of the left ventricle, which may otherwise go unnoticed," they concluded.
Reference:
Suresh Kumar, A. F., Ojha, V., Veettil, S. T., Mantoo, M., Singh, D., Pandey, N. N., Jagia, P., Yadav, S., & Kumar, S. (2024). Incremental Role of Cardiac CT Angiography in the Assessment of Left Ventricular Diastolic Function in Patients With Suspected Coronary Artery Disease With Normal Ejection Fraction: A Comparison With Transthoracic Echocardiography. Echocardiography, 42(1), e70069. https://doi.org/10.1111/echo.70069
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.